McMahon LR[au] - Search Results

Year	Number of Results
1994	1
1996	2
1997	3
1998	3
1999	2
2001	6
2002	4
2003	8
2004	2
2005	7
2006	5
2007	4
2008	6
2009	4
2010	4
2011	5
2012	6
2013	1
2014	5
2015	3
2016	6
2017	4
2018	2
2019	11
2020	17
2021	14
2022	1

1

More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Moerke MJ, McMahon LR, Wilkerson JL. Moerke MJ, et al. Among authors: mcmahon lr. Pharmacol Rev. 2020 Apr;72(2):527-557. doi: 10.1124/pr.119.018028. Pharmacol Rev. 2020. PMID: 32205338 Free PMC article. Review.

2

Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?

Wilkerson JL, Bilbrey JA, Felix JS, Makriyannis A, McMahon LR. Wilkerson JL, et al. Among authors: mcmahon lr. Pharmacol Biochem Behav. 2021 Jul;206:173192. doi: 10.1016/j.pbb.2021.173192. Epub 2021 Apr 29. Pharmacol Biochem Behav. 2021. PMID: 33932409 Review.

3

Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery.

Obeng S, Hiranita T, León F, McMahon LR, McCurdy CR. Obeng S, et al. Among authors: mcmahon lr. J Med Chem. 2021 May 27;64(10):6523-6548. doi: 10.1021/acs.jmedchem.1c00028. Epub 2021 May 6. J Med Chem. 2021. PMID: 33956427 Review.

4

Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators.

Wilkerson JL, Deba F, Crowley ML, Hamouda AK, McMahon LR. Wilkerson JL, et al. Among authors: mcmahon lr. Neuropharmacology. 2020 May 15;168:108008. doi: 10.1016/j.neuropharm.2020.108008. Epub 2020 Feb 12. Neuropharmacology. 2020. PMID: 32113032 Free PMC article. Review.

5

Green tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics.

McMahon LR. McMahon LR. Expert Rev Clin Pharmacol. 2019 Mar;12(3):189-195. doi: 10.1080/17512433.2019.1570844. Epub 2019 Jan 24. Expert Rev Clin Pharmacol. 2019. PMID: 30650314 Free PMC article. Review.

6

Hydrolysis and enzymatic degradation of Novichok nerve agents.

Harvey SP, McMahon LR, Berg FJ. Harvey SP, et al. Among authors: mcmahon lr. Heliyon. 2020 Jan 7;6(1):e03153. doi: 10.1016/j.heliyon.2019.e03153. eCollection 2020 Jan. Heliyon. 2020. PMID: 32042950 Free PMC article.

7

Pharmacokinetics and Safety of Mitragynine in Beagle Dogs.

Maxwell EA, King TI, Kamble SH, Raju KSR, Berthold EC, León F, Avery BA, McMahon LR, McCurdy CR, Sharma A. Maxwell EA, et al. Among authors: mcmahon lr. Planta Med. 2020 Nov;86(17):1278-1285. doi: 10.1055/a-1212-5475. Epub 2020 Jul 21. Planta Med. 2020. PMID: 32693425 Free PMC article.

8

In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability.

Giuffrida A, McMahon LR. Giuffrida A, et al. Among authors: mcmahon lr. Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):90-103. doi: 10.1016/j.prostaglandins.2009.05.004. Epub 2009 Jun 10. Prostaglandins Other Lipid Mediat. 2010. PMID: 19523530 Free PMC article. Review.

9

The discriminative stimulus effects of epibatidine in C57BL/6J mice.

de Moura FB, Hiranita T, McMahon LR. de Moura FB, et al. Among authors: mcmahon lr. Behav Pharmacol. 2020 Sep;31(6):565-573. doi: 10.1097/FBP.0000000000000555. Behav Pharmacol. 2020. PMID: 32209809 Free PMC article.

10

Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders.

Beardsley PM, Thomas BF, McMahon LR. Beardsley PM, et al. Among authors: mcmahon lr. Int Rev Psychiatry. 2009 Apr;21(2):134-42. doi: 10.1080/09540260902782786. Int Rev Psychiatry. 2009. PMID: 19367507 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results